Resistance to apoptosis in prostate cancer cells

Molecular Urology

Volumn 4, Issue 3, 2000, Pages 225-229+231

  Howell, S B ^a   Bruchovsky, N ^a   Garzotto, M ^a   Klotz, L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; CANCER CELL; CELL DEATH; CONFERENCE PAPER; DEINOCOCCUS RADIODURANS; DNA DAMAGE; GAMMA IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

ANDROGEN ANTAGONISTS; ANDROGENS; APOPTOSIS; BENZOTHIAZOLES; CASPASES; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; HUMANS; MALE; MICROCOCCUS; PROSTATIC NEOPLASMS; THIAZOLES; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033761312     PISSN: 10915362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Suicidal tendencies: Apoptotic cell death by caspase family proteinases
2. Death deceiver
3. Caspase activation: The induced-proximity model
4. Caspase-14 is a novel developmentally regulated protease
5. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone
6. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
7. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
8. X-linked IAP is a direct inhibitor of cell-death proteases
9. Injected cytochrome c induces apoptosis
10. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
11. Bcl-X(L) interacts with APAF-1 and inhibits APAF-1-dependent caspase-9 activation
12. DNA repair in the extremely radioresistant bacterium Deinococcus radiodurans
13. Against all odds: The survival strategies of Deinococcus radiodurans
14. The resistance of Micrococcus radiodurans to ultraviolet radiation
15. Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1
16. The biology of hormone refractory prostate cancer: Why does it develop?
17. Implications of cell death regulation in the pathogenesis and treatment of prostate cancer
18. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
19. The role of the p53 tumor suppressor gene in prostate cancer: A possible biomarker?
20. Bcl-2 and bax function independently to regulate cell death
21. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
22. Bcl-2 expression confers androgen independence in androgen sensitive prostatic carcinoma
23. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers
24. Bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer
25. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis
26. The p53 tumor suppressor gene
27. P53 function and dysfunction
28. Allelic loss of chromosomes 16q and 10q in human prostate cancer
29. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer
30. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR
31. Clinical implications of the p53 tumor suppressor gene
32. Cell proliferation, DNA repair, and p53 function are not required for programmed cell death of prostatic glandular cells induced by androgen ablation
33. 2 arrest after DNA damage
34. The steroid receptor superfamily
35. Mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
36. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors
37. Androgen receptor gene amplification: A possible mechanism for androgen deprivation therapy failure in prostate cancer
38. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
39. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
40. p53 In growth control and neoplasia
41. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains
42. Loss of ATM radiosensitizes p53 null tissues
43. The genetics of cancer: A 3D model
44. Regulation of cell death protease caspase-9 by phosphorylation
45. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells